Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Migraine Treatment in ED

Not Applicable

Withdrawn

Conditions: Migraine

Interventions: Drug: Topiramate
Behavioral: Relaxation Therapy
Drug: Standard of Care
Drug: Abortive Medication (Naproxen and Sumatriptan)

First Posted Date: 2015-12-31

Last Posted Date: 2018-08-24

Lead Sponsor: NYU Langone Health

Registration Number: NCT02643719

Stationary Bike Study

Not Applicable

Completed

Conditions: Concussion
Vertigo
Dizziness

Interventions: Other: Vestibular Rehabilitation
Other: Vestibular Rehabilitation + Aerobic Exercise

First Posted Date: 2015-12-29

Last Posted Date: 2020-01-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 27

Registration Number: NCT02640599

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Smoking Cessation Peds Asthma

Not Applicable

Withdrawn

Conditions: Smoking Cessation
Asthma

Interventions: Behavioral: Chart Reminders & New York State Quit line referral system

First Posted Date: 2015-12-29

Last Posted Date: 2016-12-12

Lead Sponsor: NYU Langone Health

Registration Number: NCT02640521

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Alcohol Versus Chlorhexidine With and Without Water

Not Applicable

Withdrawn

Conditions: Infection

Interventions: Other: Chlorhexidine + sterillium hand rub
Other: Chlorhexidine with water rinse
Other: Chlorhexidine without water rinse

First Posted Date: 2015-12-29

Last Posted Date: 2017-01-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT02640469

Locations: 🇺🇸
New York University Hospital for Joint Disease, New York, New York, United States

Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

Completed

Conditions: Multiple System Atrophy
REM Sleep Behavior Disorder
Dementia With Lewy Bodies
Pure Autonomic Failure
Parkinson Disease

First Posted Date: 2015-12-28

Last Posted Date: 2020-12-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 166

Registration Number: NCT02640339

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Altering Bicarbonate Delivery During Hemodialysis to Affect Filtration of Indoxyl Sulfate

Not Applicable

Withdrawn

Conditions: Renal Dialysis
Hemodialysis

Interventions: Drug: Low bicarbonate dialysate First
Drug: Normal bicarbonate dialysate First
Drug: Normal bicarbonate dialysate
Drug: Low bicarbonate dialysate

First Posted Date: 2015-12-24

Last Posted Date: 2017-07-31

Lead Sponsor: NYU Langone Health

Registration Number: NCT02639624

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders

Not Applicable

Withdrawn

Conditions: Breast Cancer

Interventions: Other: No Acupuncture Treatment
Other: Immediate Post Operative Acupuncture Treatment

First Posted Date: 2015-12-24

Last Posted Date: 2016-08-03

Lead Sponsor: NYU Langone Health

Registration Number: NCT02639611

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars

Not Applicable

Completed

Conditions: COPD

Interventions: Other: Active smoking of Tobacco Hookah for 2 hours
Other: Exposure to tobacco hookah second hand smoke
Other: Visit a win bar

First Posted Date: 2015-12-23

Last Posted Date: 2015-12-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 26

Registration Number: NCT02638194

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

Phase 2

Completed

Conditions: Attention Deficit Disorder
Attention Deficit Hyperactivity Disorder

Interventions: Drug: Lisdexamfetamine
Drug: Placebo

First Posted Date: 2015-12-18

Last Posted Date: 2021-11-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 38

Registration Number: NCT02635035

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States
🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Falls Prevention: Gait-Synchronized Vibration System

Not Applicable

Withdrawn

Conditions: Sensory Deficits

Interventions: Device: Gait Synchronized Vibration System

First Posted Date: 2015-12-18

Last Posted Date: 2019-01-10

Lead Sponsor: NYU Langone Health

Registration Number: NCT02635113

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy